Clinical Trials Logo
  1. Home
  2. Tourette Syndrome in Adolescence
  3. NCT05184478

Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study

Tourette Syndrome in Adolescence Clinical Trial

Official title:
A Pilot Randomized Placebo-controlled Crossover Trial of Medicinal Cannabis (MC) in Adolescents With Tourette Syndrome (TS)

Clinical Trial Summary

This is a single site, pilot double-blind, randomized, placebo-controlled, cross-over study of 10 participants comparing medicinal cannabis (THC:CBD 10:15 oil) with placebo in reducing tics in adolescents aged 12 - 18 years with severe Tourette Syndrome (TS). The primary objective of this pilot study is to evaluate all elements of the study design (recruitment strategy, study duration, study procedures, study medication tolerance and outcome measures) to assess if they are acceptable and feasible for the conduct of a full-scale randomized controlled trial of THC:CBD 10:15 oil to reduce tic severity in adolescents with TS. The secondary objective of this study is to collect preliminary data on the safety of oral THC:CBD 10:15 oil in adolescents aged 12 to 18 years with TS. As an exploratory aim data from clinician- and parent-rated measures will be compared across the phases to explore for a signal of efficacy on primary (tic reduction) and secondary (premonitory urges, obsessive compulsive behaviors, Attention Deficit Hyperactivity Disorder [ADHD] symptoms) outcome measures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05184478
Study type Interventional
Source Murdoch Childrens Research Institute
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 16, 2022
Completion date January 4, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05566236 - Board Game Project for Adolescents With Tourette Syndrome N/A
Completed NCT04114539 - Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT05558566 - Neurofeedback From the Supplementary Motor Area for Tourette Syndrome N/A
Recruiting NCT05628805 - Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome Early Phase 1
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Not yet recruiting NCT05188274 - A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome N/A
Recruiting NCT05696769 - Tourette Discrimination (TD) Stigma Scale
Completed NCT04449003 - Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
Recruiting NCT04087616 - Internet-based CBIT for Children With Chronic Tics N/A
Completed NCT03765463 - Extinction Learning in Youth With Tourette Syndrome N/A
Completed NCT05434546 - A Study to Explore the Effect of Sepranolone in Tourette Syndrome Phase 2
Not yet recruiting NCT04179435 - Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome N/A
Recruiting NCT06385535 - Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder N/A